Advanced search
Publication Cover
Future Oncology Volume 17, 2021 - Issue 1
Submit an article Journal homepage
699
Views
0
CrossRef citations to date
0
Altmetric
Drug Evaluation

Alpelisib in the Treatment of Metastatic HR+ Breast Cancer with PIK3CA Mutations

Athanasios Mavratzas1 Department of Obstetrics & Gynecology Mannheim, Section of Conservative Gynecologic Oncology,Experimental & Translational Gynecologic Oncology,Medical Faculty Mannheim of University Heidelberg University Hospital,Mannheim, Theodor-Kutzer-Ufer 1-3,68167,Mannheim,GermanyCorrespondence[email protected]
&
Frederik Marmé1 Department of Obstetrics & Gynecology Mannheim, Section of Conservative Gynecologic Oncology,Experimental & Translational Gynecologic Oncology,Medical Faculty Mannheim of University Heidelberg University Hospital,Mannheim, Theodor-Kutzer-Ufer 1-3,68167,Mannheim,Germany
Pages 13-36 | Received 09 May 2020, Accepted 12 Aug 2020, Published online: 23 Sep 2020

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.